India’s pharmaceutical industry has seen a year of both challenges and progress in 2024. India is the third largest global market for pharmaceuticals in terms of volume, and has remained an important player in the global healthcare ecosystem, especially in the generics and biosimilars space. The digitalization of the industry has been one of the most defining trends within the industry in 2024, and the pace of which has accelerated significantly. AI, machine learning and big data analytics are the technologies used by companies in the drug discovery, manufacturing, and distribution... >>More
Saji Mathew, Chief Operating Officer, Baby Memorial Hospital
Dr. Dyotona Sen, Head - Medical Affairs & Clinical Research, Galderma
Akhil Ravi, CEO, Aurigene Pharmaceutical Services
Vaibhav Tewari, Co- Founder & CEO, Portea
Dileep Mangsuli, Senior Vice President - Global Access to Care, Siemens Healthineers
David Ewing Duncan, Researcher & CEO, Arc Fusion
Vickram Srivastava, Head - Planning, Global Supply Chain, Sun Pharma
Manoj Jagathmohan, Director & Head, India & South Asia, QIAGEN
Shweta Rai, Managing Director, Bayer Pharmaceuticals
Dr. Shirish Alurkar, Sr. Consultant- Medical Oncology, HCG Cancer Centre
